Organovo Holdings, Inc. - Nilai Total Perusahaan ONVO

Organovo Holdings, Inc. (ONVO) management relies on a powerful scientific foundation, although preclinical research experience has not yet converted into profit. The business generates revenue through the licensing of patents for 3D tissue printing used in pharmaceutical testing. This price chart reflects an Enterprise Value of . The brand maintains its reputation as a recognized pioneer in the bioprinting field, enjoying the trust of the expert community.

The scale of Organovo Holdings, Inc. (ONVO) as an innovator in 3D bioprinting of tissues for pharmaceutical R&D defines the fundamental basis of the business value. This indicator aggregates market capitalization and net debt to reflect the actual cost of acquiring the company, allowing the total enterprise value to determine a fair premium for the uniqueness of the NovoGen technology.